Literature DB >> 24871501

Is there a future for tigecycline?

Matteo Bassetti1, Garyfallia Poulakou, Helen Giamarellou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24871501     DOI： 10.1007/s00134-014-3343-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  34 in total

1.  Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia.

Authors:  Antonio T Freire; Vasyl Melnyk; Min Ja Kim; Oleksiy Datsenko; Oleksandr Dzyublik; Felix Glumcher; Yin-Ching Chuang; Robert T Maroko; Gary Dukart; C Angel Cooper; Joan M Korth-Bradley; Nathalie Dartois; Hassan Gandjini
Journal:  Diagn Microbiol Infect Dis       Date:  2010-10       Impact factor: 2.803

Review 2.  Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease.

Authors:  Yun Cai; Rui Wang; Beibei Liang; Nan Bai; Youning Liu
Journal:  Antimicrob Agents Chemother       Date:  2010-12-20       Impact factor: 5.191

3.  Clinical experience of tigecycline treatment in infections caused by extensively drug-resistant Acinetobacter spp.

Authors:  Soo-Youn Moon; Kyong Ran Peck; Hyun-Ha Chang; Shin-Woo Kim; Sang Taek Heo; Jun Seong Son; Seong Yeol Ryu; Chisook Moon; Sook-In Jung; Sang Yop Shin; Jeong-a Lee; Mi-Kyong Joung; Doo-Ryeon Chung; Cheol-In Kang; Jae-Hoon Song
Journal:  Microb Drug Resist       Date:  2012-07-09       Impact factor: 3.431

4.  Clinical experience with tigecycline in the treatment of carbapenem-resistant Acinetobacter infections.

Authors:  G Metan; E Alp; O Yildiz; D Percin; B Aygen; B Sumerkan
Journal:  J Chemother       Date:  2010-04       Impact factor: 1.714

Review 5.  Efficacy and safety of tigecycline: a systematic review and meta-analysis.

Authors:  Dafna Yahav; Adi Lador; Mical Paul; Leonard Leibovici
Journal:  J Antimicrob Chemother       Date:  2011-06-18       Impact factor: 5.790

6.  Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli.

Authors:  Fernando Docobo-Pérez; Patrice Nordmann; Juan Domínguez-Herrera; Rafael López-Rojas; Younes Smani; Laurent Poirel; Jerónimo Pachón
Journal:  Int J Antimicrob Agents       Date:  2011-12-07       Impact factor: 5.283

7.  Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.

Authors:  W Jamal; M Salama; N Dehrab; G Al Hashem; M Shahin; V O Rotimi
Journal:  J Hosp Infect       Date:  2009-06-03       Impact factor: 3.926

8.  A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.

Authors:  Krasimir Vasilev; Galina Reshedko; Remus Orasan; Miguel Sanchez; Juri Teras; Tim Babinchak; Gary Dukart; Angel Cooper; Nathalie Dartois; Hassan Gandjini; Russ Orrico; Evelyn Ellis-Grosse
Journal:  J Antimicrob Chemother       Date:  2008-09       Impact factor: 5.790

9.  Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections.

Authors:  Y-T Lee; S-M Tsao; P-R Hsueh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-05       Impact factor: 3.267

10.  Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens.

Authors:  Garyphallia Poulakou; Flora V Kontopidou; Elisabeth Paramythiotou; Maria Kompoti; Maria Katsiari; Efstratios Mainas; Chara Nicolaou; Dimitrios Yphantis; Anastasia Antoniadou; Eleftheria Trikka-Graphakos; Zoi Roussou; Phyllis Clouva; Nina Maguina; Kyriaki Kanellakopoulou; Apostolos Armaganidis; Helen Giamarellou
Journal:  J Infect       Date:  2009-04       Impact factor: 6.072
View more
  3 in total

1.  Tigecycline Therapy for Multi-drug-Resistant Pseudomonas aeruginosa Sepsis Associated with Multi-organ Failure in an Infant with Persistent Arterial Duct. Case Report.

Authors:  Veronika Krasnanova; Lubica Kovacikova
Journal:  SN Compr Clin Med       Date:  2020-07-13

Review 2.  What's new in multidrug-resistant pathogens in the ICU?

Authors:  Gabor Zilahi; Antonio Artigas; Ignacio Martin-Loeches
Journal:  Ann Intensive Care       Date:  2016-10-06       Impact factor: 6.925

3.  Evolutionary Trajectories toward Ceftazidime-Avibactam Resistance in Klebsiella pneumoniae Clinical Isolates.

Authors:  Alessandra Carattoli; Gabriele Arcari; Giulia Bibbolino; Federica Sacco; Dario Tomolillo; Federica Maria Di Lella; Maria Trancassini; Luigi Faino; Mario Venditti; Guido Antonelli; Giammarco Raponi
Journal:  Antimicrob Agents Chemother       Date:  2021-08-02       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.